Hydroxyapatite (HA) bone scaffolds with controlled macrochannel pores.

Current research in tissue engineering seeks to optimize scaffold structures for bone regeneration. It was already known that scaffold porosity influences mechanical properties and cell behavior. No prior work had resolved how controlled macrochannel pores affect both mechanical strength and cell proliferation in hydroxyapatite scaffolds. Existing studies have shown that higher porosity often correlates with better cell infiltration and nutrient transport. However, the trade-off with reduced mechanical strength remains a challenge. This gap motivated researchers to explore a balance between porosity and structural integrity. The need for reproducible fabrication methods led to the use of extrusion and lamination techniques. These approaches allow precise control over pore architecture. The uncertainty around how porosity affects osteoblast activity drove this investigation.

The study aimed to fabricate hydroxyapatite scaffolds with controlled macrochannel pores using extrusion and lamination. The goal was to assess how porosity affects mechanical strength and cell response. Researchers wanted to determine if increased porosity could enhance osteoblast activity without compromising structural integrity. They hypothesized that adjusting HA and carbon filament fractions would control porosity. The specific problem addressed was the lack of reproducible methods for creating macrochannel scaffolds. The motivation came from the need to optimize both mechanical and biological performance. This work sought to bridge the gap between scaffold design and functional outcomes. The study focused on achieving a balance between porosity and compressive strength.

The fabrication process combined extrusion and lamination to create macrochanneled scaffolds. HA and carbon filaments were aligned and layered to form the scaffold structure. Carbon filaments served as a sacrificial template for pore formation. After lamination, the scaffolds underwent thermal treatments to remove the binder. Sintering followed to consolidate the HA structure. The porosity was adjusted by varying the HA and carbon filament fractions. Pore size was controlled to remain approximately 450 micrometers. Mechanical testing measured compressive strength at different porosity levels.

Scaffold porosity ranged from 48% to 73% with controlled pore sizes of about 450 micrometers. As porosity increased, compressive strength decreased from 11.5 MPa to 3.2 MPa. Osteoblast-like cell proliferation improved with higher porosity levels. Alkaline phosphatase (ALP) activity also increased with greater porosity. The controlled pore architecture allowed consistent mechanical and biological testing. The extrusion-lamination method enabled precise pore size control. Cell responses were significantly enhanced at higher porosity levels. These findings suggest a direct relationship between scaffold porosity and cell activity.

The authors propose that increasing scaffold porosity enhances osteoblast activity despite reduced mechanical strength. The extrusion-lamination method effectively controls pore structure and size. The study suggests that porosity levels above 48% support better cell proliferation and ALP activity. The observed decrease in compressive strength with higher porosity is consistent with prior findings. The controlled pore architecture allows for reproducible scaffold fabrication. The results suggest a trade-off between mechanical and biological performance. The study supports the use of macrochannel scaffolds for bone regeneration applications. These findings may guide future scaffold design for tissue engineering.